mitomycin has been researched along with thymalfasin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Cheng, SQ; Cong, WM; Shen, F; Wang, PJ; Wu, MC; Yang, JH; Zhao, YX | 1 |
| Abu-Abeid, A; Bar-David, S; Dayan, D; Lahat, G; Lee Goldstein, A; Nevo, N; Nizri, E | 1 |
1 trial(s) available for mitomycin and thymalfasin
| Article | Year |
|---|---|
[Transcatheter hepatic arterial chemoembolization and thymosin alpha1 in postoperative treatment of hepatocellular carcinoma].
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Carboplatin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Female; Hepatectomy; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Postoperative Period; Survival Rate; Thymalfasin; Thymosin | 2004 |
1 other study(ies) available for mitomycin and thymalfasin
| Article | Year |
|---|---|
Immunological effects of heated intraperitoneal chemotherapy can be augmented by thymosin α1.
Topics: Animals; Colorectal Neoplasms; Combined Modality Therapy; Hyperthermia, Induced; Mice; Mitomycin; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Survival Rate; Thymalfasin | 2023 |